Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
0.9000
+0.0299 (3.44%)
At close: Nov 3, 2026, 4:00 PM EST
0.9130
+0.0130 (1.44%)
After-hours: Nov 3, 2026, 5:45 PM EST
Imunon Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
20
Market Cap
5.05M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 500.00K | - | - |
| Dec 31, 2021 | 500.00K | - | - |
| Dec 31, 2020 | 500.00K | - | - |
| Dec 31, 2019 | 500.00K | - | - |
| Dec 31, 2018 | 500.00K | - | - |
| Dec 31, 2017 | 500.00K | - | - |
| Dec 31, 2016 | 500.00K | - | - |
| Dec 31, 2015 | 500.00K | - | - |
| Dec 31, 2014 | 500.00K | - | - |
| Dec 31, 2013 | 500.00K | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | 2.00M | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | 2.50M | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Xenetic Biosciences | 3.26M |
| Traws Pharma | 2.73M |
| Evogene | 1.66M |
| Longeveron | 1.19M |
| Can-Fite BioPharma | 405.00K |
| AIM ImmunoTech | 95.00K |
| Cardio Diagnostics Holdings | 14.45K |
| Azitra | 7.50K |
IMNN News
- 1 day ago - IMUNON to Hold Third Quarter 2026 Financial Results and Business Update Conference Call on Thursday, November 12, 2026 - GlobeNewsWire
- 6 days ago - Imunon Registration statement: Registration filing - Filings
- 7 days ago - Imunon Registration statement: Registration filing - Filings
- 7 days ago - Imunon files to sell 20M shares of common stock, pre-funded warrants - TheFly
- 13 days ago - Imunon to sell ThermoDox rights to VoxelDox Therapeutics for ownership stake - TheFly
- 13 days ago - IMUNON Announces Strategic Sale of ThermoDox® - GlobeNewsWire
- 26 days ago - IMUNON to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - IMUNON Converts $1.2 Million of Debt-to-Equity - GlobeNewsWire